Selective Serotonin Reuptake Inhibitors (SSRIs) in Borderline Personality Disorder

计划入组 70 人 · 首次发布于 2010 年 4 月 14 日

sElective Serotonin reuPtake inhibitoRs In posT-covid After COVID-19

计划入组 160 人 · 首次发布于 2026 年 1 月 22 日

Do Serotonin Reuptake Inhibitors (SSRIs) Affect Bone Mass in Adolescents

计划入组 287 人 · 首次发布于 2014 年 5 月 26 日

serotonin reuptake inhibitors (topical, wounds)

Serotonin

C₁₀H₁₂N₂O

Non-selective Serotonin Reuptake Inhibitor(Enveric)

Adial Pharmaceuticals

United States

UPTAKE MEDICAL CORP

United States

Uptake Medical Technology, Inc.

United States

Evecxia Therapeutics Gains FDA Support for EVX-101 Depression Trial

Three Novel Anxiety Medications Advance Toward 2026 FDA Review, Marking First Major Breakthrough in Over a Decade

Otsuka Submits FDA Application for First-in-Class ADHD Drug Centanafadine